Fundraising Fox
/Companies
Sign in

ApoGen Biotechnologies

Seattle, US · Founded 2014 · Delaware corporation · 4 known investors

Find your way into ApoGen Biotechnologies

Sign up to find every way you can get introduced to ApoGen Biotechnologies

  • Your email: who you already know at ApoGen Biotechnologies, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ApoGen Biotechnologies team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in
Biotech

Founders & leadership

TL
Thong LeNamed on SEC filing
KG
Keno GutierrezNamed on SEC filing
JS
John SantiniNamed on SEC filing
MJ
M. Johnston ErwinNamed on SEC filing
IA
Ian A.W. HowesNamed on SEC filing
JM
Joel MarcusNamed on SEC filing
JS
James SullivanNamed on SEC filing

Board

SG
Steve GillisBoard directorManaging Director at ARCH Venture Partners
AXAsish Xavier
Asish XavierBoard directorVice President, Venture Investments at JJDC

Investors · 4

Johnson & Johnson Innovation – JJDCreportedNew Brunswick

How we know: funding news · Not right? Tell us

M VenturesreportedLos Angeles · $10.8M

How we know: a partner's Signal profile · press coverage · Not right? Tell us

WRF CapitalreportedSeattle · $100K – $2M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$7.6M disclosed across 1 of 2 rounds · 2016–2018

▶$7.6MraisedAug 2018 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thong LeExecutive Officer, Director
  • Keno GutierrezDirector
  • Steve GillisDirector
  • John SantiniDirector
  • M. Johnston ErwinDirector
  • Asish XavierDirector
  • Ian A.W. HowesExecutive Officer
  • Joel MarcusDirector
  • James SullivanDirector
Offering amount
$7.6M
Amount sold
$7.6M
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are ApoGen Biotechnologies's investors?
ApoGen Biotechnologies's investors include ARCH Venture Partners, Johnson & Johnson Innovation – JJDC, M Ventures, WRF Capital.
How much funding has ApoGen Biotechnologies raised?
ApoGen Biotechnologies has disclosed $7.6M raised across 1 of its 2 known rounds.
Where is ApoGen Biotechnologies headquartered?
ApoGen Biotechnologies is headquartered in Seattle, US.